4559
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Zeria Pharmaceutical Co., Ltd. is a pharmaceutical company operating through its medical pharmaceuticals and consumer healthcare segments. The group manufactures, procures, and sells prescription drugs and over-the-counter (OTC) medicines, health foods, and cosmetics. Key subsidiaries include Tillotts Pharma AG, which handles the manufacturing and sales of medical pharmaceuticals in Europe, and Pharmaceutical Joint Stock Company of February 3rd, which produces and sells both medical and OTC products. Zeria Health Way sells health foods, while Iona International manufactures and sells cosmetics and quasi-drugs. ZPD A/S focuses on the production and sale of pharmaceutical raw materials. The company also engages in insurance agency, real estate, and maintenance services through subsidiaries such as Zavis and Zeria Ectech. The group serves markets in Japan and Europe, providing products for self-medication and professional healthcare use.

Summarised from the annual report, fiscal year ended Mar 2026

Industry Drug Manufacturers - General Homepage zeria.co.jp
Sector Healthcare IR page zeria.co.jp
Tags
prescription drugs, otc medicines, health foods, cosmetics, pharmaceutical raw materials, self-medication, insurance agency, real estate, Tillotts Pharma AG, Tillotts Pharma AB, Zeria Up, Pharmaceutical Joint Stock Company of February 3rd, Zeria Health Way, Iona International, ZPD A/S, Zavis, Zeria Trading, Zeria Ectech
Press page zeria.co.jp/news

Metrics

Valuation  
Market cap ¥ 98.584B
Market cap (USD) $ 616.16M
P/E 8.12
PEG 0.74
P/BV 0.89
P/S 1.04
P/OCF 8.08
P/FCF 10.44
Dividend yield 2.5%
Turnover / mcap —
Returns  
ROE 8.5%
ROI 5.7%
ROIC 6.3%
Profit margin 9.5%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 10.9%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 10
Quality score 38.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Revenue 89.159B 87.311B 75.725B 68.383B 59.533B 55.442B 60.427B 61.832B 64.569B 64.85B 62.475B 61.013B 61.997B 53.318B
Net profit 8.455B 9.936B 7.731B 6.196B 3.961B 3.12B 2.925B 3.454B 4.158B 3.544B 3.513B 2.558B 5.277B 3.982B
Free cash flow 7.06B 10.188B 8.285B 10.5B 7.53B -9.238B 5.978B 3.983B 6.779B 3.516B -23.253B — — —

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013
Share price 2.189K 2.256K 2.135K 2.246K 1.904K 2.105K 2.086K 1.914K 2.129K 1.713K 1.462K 2.012K 2.097K 1.322K
Price performance 12m -0.03 0.06 -0.05 0.18 -0.1 0.01 0.09 -0.1 0.24 0.17 -0.27 -0.04 0.59 —

Filed figures

Figure Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Balance sheet detail
Trade receivables (JPY) 16.6B 15.6B 15B 13.4B 13.6B 16.2B 17.5B 21.2B 26.7B 31.4B
↳ YoY growth +12.6% -6.1% -4.2% -10.6% +2.0% +18.9% +8.1% +21.3% +25.8% +17.6%
↳ 5y CAGR -1.6% -0.5% +2.3% +7.3% +14.9% +18.2%
Borrowings, current (JPY) 33.1B 24.9B 28B 29.7B 44.2B 33.8B 34.9B 38.3B 34.3B 33.8B
Borrowings, non-current (JPY) 2.88B 8.68B 7.8B 5.47B 5.82B 18.4B 14.5B 7.94B 6.87B 5.27B
Cash and deposits (JPY) 9.25B 10.2B 8.05B 9.01B 9.79B 11.7B 16.2B 20.3B 23.6B 27.8B
Intangible assets (JPY) 33.9B 32.3B 29.8B 29.8B 42.1B 41.2B 41.9B 43.1B 40.4B 39.6B
Net debt (borrowings + leases - cash) (JPY) 26.7B 23.4B 27.7B 26.2B 40.2B 40.5B 33.2B 25.9B 17.6B 11.3B
Cash flow detail
Operating cash flow (JPY) 7.24B 8.82B 5.5B 7.25B 6.89B 8.95B 13.2B 12.2B 12.9B 9.96B
Purchases of property, plant and equipment (JPY) -1.67B -1.78B -1.09B -622M -734M -1.06B -2.4B -2.9B -1.43B -2.36B
Purchases of intangible assets (JPY) -2.05B -258M -429M -651M -15.4B -357M -258M -998M -1.3B -535M
Change in receivables (cash effect) (JPY) -2.08B 1.1B 495M 1.57B 826M -2.03B -172M -2.08B -4.8B -1.9B
Change in inventories (cash effect) (JPY) -717M -707M -752M 456M -754M -542M -150M -864M -1.65B -3.42B
Change in payables (cash effect) (JPY) 256M -214M -287M -174M -40.7M 284M -208M 1.05B 567M 521M
Dividends paid (cash effect) (JPY) -1.69B -1.71B -1.7B -1.6B -1.57B -1.54B -1.59B -1.94B -1.98B -2.11B
Share buybacks (cash effect) (JPY) -552,000 -5.61B -4.98B -3.29B -1.15B -2.6B -674M -824,000 -662,000 -258,000
Interest paid (cash effect) (JPY) -289M -187M -200M -233M -224M -305M -301M -447M -492M -498M
Income taxes paid (cash effect) (JPY) -453M -440M -1.08B -1B -527M -875M -564M -916M -1B -2.74B
Operating cash flow before change in receivables (JPY) 9.32B 7.72B 5.01B 5.68B 6.07B 11B 13.3B 14.3B 17.7B 11.9B
Free cash flow (OCF - PPE - intangibles) (JPY) 3.52B 6.78B 3.98B 5.98B -9.24B 7.53B 10.5B 8.28B 10.2B 7.06B
Income detail
Research and development expense (JPY) 8.46B 7.33B 6.83B 6.34B 5.41B 4.79B 3.46B 3.73B 4.11B 3.71B
↳ 5y CAGR -8.8% -10.8% -14.0% -11.4% -8.3% -7.3%
Total comprehensive income (JPY) 1.69B 9.51B 350M -1.47B 6.23B 2.99B 12.9B 16.1B 12B 20.9B
Comprehensive income to owners (JPY) 1.69B 9.49B 346M -1.48B 6.22B 2.96B 12.8B 16.1B 11.9B 21B
Reported Jun 29, 2017 Jun 28, 2018 Jun 27, 2019 Jun 26, 2020 Jun 29, 2021 Jun 29, 2022 Jun 29, 2023 Jun 27, 2024 Jun 26, 2025 Jun 25, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Zeria Pharmaceutical Co., Ltd. (ticker 4559), listed in Japan.

ETFs Holding Zeria Pharmaceutical Co., Ltd.

ETF Weight in ETF Shares Market value As of
DISV 0.01% 55,500 $ 723.34K Nov 12, 2026
DFIS 0.01% 46,500 $ 606.041K Nov 12, 2026
DXIV 0.01% 1,900 $ 24.763K Nov 12, 2026
AVDV 0.01% 94,600 $ 1.249M Nov 16, 2026
AVDS 0.01% 3,100 $ 40.917K Nov 16, 2026
DFIC 0.00% 32,522 $ 423.864K Nov 12, 2026
DFAX 0.00% 20,500 $ 267.179K Nov 12, 2026
DFSI 0.00% 1,700 $ 22.156K Nov 12, 2026
DFAI 0.00% 19,383 $ 252.621K Nov 12, 2026
AVDE 0.00% 42,300 $ 558.319K Nov 16, 2026